The NIZHPHARM Group (formerly part of the STADA Group) is one of Russia's leading manufacturers of high-quality pharmaceutical products, with a 105-year history. Our key business areas include: • The over-the-counter (OTC) segment, dietary supplements, and medical devices. • The prescription drug segment, which includes both original medicines and generics. NIZHPHARM's product portfolio encompasses pharmaceuticals across more than 17 therapeutic areas, with a focus on cardiology, endocrinology, neurology, and men's and women's health (reproductive health). Our portfolio is a unique combination of localized original socially significant drugs (60%) and products we import into Russia (40%). The NIZHPHARM Group includes two production sites: Nizhpharm JSC in Nizhny Novgorod and Hemofarm LLC in Obninsk, which enables us to further develop our business with a focus on the local needs of partners and patients in Russia. Today, NIZHPHARM employs over 2,200 people.